ADVOCACY, AWARENESS-RAISING AND INFORMATION
The International Brain Tumour Alliance (IBTA) is a unique global network for brain tumour patient and carer groups around the world. We work alongside, and represent, members of our community – including researchers, scientists, clinicians, nurses and allied healthcare professionals – to engage in advocacy, to raise awareness and to share information.
New resource for people affected by brain metastases
A brain metastases diagnosis raises many questions, often all at once. The Brain Metastases PATHWAY is an internationally-endorsed interactive guide designed to help people living with brain metastases from breast, lung, colorectal and kidney cancers. and from melanoma. PATHWAY is aimed at patients, caregivers and loved ones, helping them find reliable, evidence-based information at every stage of their journey. Developed by the Brain Metastases International Collaborative (BMIC), PATHWAY covers diagnosis, treatment and clinical trials, everyday wellbeing, and planning for the future. You can explore it at your own pace, returning to it whenever your circumstances or questions change.
Read the Brain Metastases Pathway PDF here »
Roche Products Ltd has provided funding for agency support in the development of this resource. Roche has had no input into the content.
IN THE SPOTLIGHT – LATEST ARTICLES AND NEWS
The IBTA's monthly e-News has now been released and been emailed to all subscribers.
The IBTA's monthly e-News has now been released and been emailed to all subscribers.
The 6th Biennial World Summit of Brain Tumour Patient Advocates was held in Rome, Italy, in November 2025.
The IBTA's monthly e-News has now been released and been emailed to all subscribers.
The Report of the 6th Biennial World Summit of Brain Tumour Patient Advocates is available now! Read it online or download here.
The 2024/2025 World Edition of Brain Tumour magazine is now available! Request a free copy here or read it online now.
The IBTA is a proud associate partner of EURACAN, the European Reference Network (ERN) for rare adult solid tumours which includes a subgroup for brain tumours.
Please click here for more information about EURACAN.
What we do
Advocacy
We collaborate with government agencies, health professional and cancer organisations, pharmaceutical companies, clinicians and research institutes and patient advocacy organisations around the world.
Find out more
Awareness-raising
We strive for wider public recognition of the unique challenges patients with this devastating disease and their families face.
Find out more
Information
We publish a monthly e-News with items of interest to the international brain tumour community. We also publish a periodic magazine called Brain Tumour which is sent for free to recipients in 110 countries.
Subscribe to Brain Tumour magazine and IBTA e-News
Events and conferences
We maintain a constantly updated list of major regional, national and international neuro-oncology conferences and other meetings relevant to brain tumours.
Find out more
Clinical trials
We maintain a list of key online clinical trial portals to help patients and carers locate clinical trial centres and understand criteria for joining a brain tumour trial.
Find out more
Ways you can support us
We would love to hear from you if you’d like to join our Alliance, help promote the IBTA, become a corporate sponsor, learn more about an awareness-raising event or make a donation.
Find out more
The IBTA is grateful to all those who have donated in-kind, pro bono and funding assistance to the IBTA since its establishment in 2005, including grants AND SPONSORSHIPS from the following companies and foundations in the years 2020, 2021, 2022, 2023, 2024 and 2025:
